Polycystic Ovary Syndrome: A Major but Underrecognized Threat to Women's Health

Polycystic ovary syndrome (PCOS) affects millions of women globally, increasing risks for heart disease, diabetes, and mental health issues. Despite its prevalence, PCOS is often underdiagnosed and undertreated, highlighting the need for greater awareness and personalized care.
Polycystic ovary syndrome (PCOS) is a common hormonal disorder affecting about 10% of women worldwide, including a significant number of women in Canada. Unlike ovarian cysts, which are fluid-filled sacs in or on the ovary, PCOS involves hormonal imbalances that lead to enlarged ovaries with multiple follicles, irregular menstrual cycles, and numerous health complications.
Despite being identified nearly a century ago, PCOS remains underdiagnosed and undertreated. Many women experience symptoms such as irregular periods, excess facial and body hair (hirsutism), thinning or loss of hair, acne, oily skin, and weight gain. Unfortunately, these symptoms are often dismissed or misunderstood by healthcare providers, leading to delays in diagnosis that can span several years.
The implications of undiagnosed or untreated PCOS are profound. Women with this condition are 20% to 40% more likely to face adverse health outcomes, including hypertension, kidney disease, gastrointestinal issues, depression, and anxiety. Importantly, they are at a two to three times higher risk of developing cardiovascular diseases like heart attack and stroke, which tend to occur three to four years earlier than average. This elevates the importance of early detection and effective management.
Managing PCOS involves lifestyle modifications such as healthy eating, regular exercise, adequate sleep, and stress reduction techniques like yoga and mindfulness. Medical interventions may include hormone regulation and treatment for associated conditions like high cholesterol and diabetes. Since there is currently no cure, early diagnosis and tailored treatment plans are crucial.
Research efforts are ongoing globally, with recent guidelines advocating for individualized treatment approaches combining lifestyle changes, medical management, and regular screening for related health issues. In Canada, initiatives like Alberta’s clinical pathway seek to improve recognition and treatment of PCOS. Involvement of patient voices through advisory councils and advocacy organizations enhances awareness and research on this underappreciated condition.
Enhancing understanding, diagnosis, and treatment of PCOS is vital to improving women’s health outcomes worldwide, reducing the risk of serious illness and improving life quality for affected women.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Comprehensive Pan-Disease Molecular Atlas Reveals Unique Blood Protein Signatures for Health, Disease, and Aging
A novel molecular map of blood proteins has been developed, revealing unique signatures associated with various diseases and aging, paving the way for improved early diagnosis and personalized medicine.
Impact of Smoking and Biological Sex on Healthy Bladder Tissue and Cancer Risk
New research reveals how smoking and biological sex influence healthy bladder tissue evolution, uncovering early markers of bladder cancer risk and opening pathways for improved prevention and early detection.
Research Reveals US Self-Reported Race and Ethnicity Don't Accurately Reflect Genetic Ancestry
New research shows that self-reported race and ethnicity in the US do not accurately reflect an individual's true genetic ancestry, highlighting implications for personalized medicine.



